Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
May 18, 2018
Finance
China comes to Europe
...Cancer Congenica Ltd. (U.K.) $9.9 Series B Amadeus Capital Partners, Cambridge Innovation Capital, Parkwalk Advisors,
Healthlink Capital
...
Read More
BioCentury
|
May 5, 2017
Financial News
Congenica completes series B round
...in the second and final tranche of a series B round. New investors BGI Genomics,
Healthlink Capital
...
Read More
BioCentury
|
Apr 14, 2017
Financial News
Lyndra completes venture financing
...A round led by Polaris Partners on April 13. Quark Venture, GF Securities, Yonghua Capital,
Healthlink Capital
...
Read More
BioCentury
|
Apr 13, 2017
Financial News
Lyndra raises $23M in series A
...Polaris Partners. Also participating were Quark Venture, GF Securities Co. Ltd. (SZSE:000776; HKSE:1776), Yonghua Capital,
Healthlink Capital
...
Read More
BioCentury
|
Aug 18, 2016
Emerging Company Profile
Negative thinking for brain cancer
...employees: 3 Funds raised: $22.5 million Investors: Eshelman Ventures, Celgene Corp. , TaiAn Technologies Corporation,
Healthlink Capital
...
Read More
BioCentury
|
Jul 18, 2016
Financial News
Sapience completes venture financing
...2016-07-12 Type: Venture financing Raised: $22.5 million Investors: Eshelman Ventures; Celgene Corp. ; TaiAn Technologies;
Healthlink Capital
WIR...
Read More
BioCentury
|
Jul 13, 2016
Financial News
Cancer newco Sapience raises $22.5M
...an untranched series A round led by Eshelman Ventures. Celgene Corp. (NASDAQ:CELG), TaiAn Technologies and
Healthlink Capital
...
Read More
Items per page:
10
1 - 7 of 7
BioCentury
|
May 18, 2018
Finance
China comes to Europe
...Cancer Congenica Ltd. (U.K.) $9.9 Series B Amadeus Capital Partners, Cambridge Innovation Capital, Parkwalk Advisors,
Healthlink Capital
...
Read More
BioCentury
|
May 5, 2017
Financial News
Congenica completes series B round
...in the second and final tranche of a series B round. New investors BGI Genomics,
Healthlink Capital
...
Read More
BioCentury
|
Apr 14, 2017
Financial News
Lyndra completes venture financing
...A round led by Polaris Partners on April 13. Quark Venture, GF Securities, Yonghua Capital,
Healthlink Capital
...
Read More
BioCentury
|
Apr 13, 2017
Financial News
Lyndra raises $23M in series A
...Polaris Partners. Also participating were Quark Venture, GF Securities Co. Ltd. (SZSE:000776; HKSE:1776), Yonghua Capital,
Healthlink Capital
...
Read More
BioCentury
|
Aug 18, 2016
Emerging Company Profile
Negative thinking for brain cancer
...employees: 3 Funds raised: $22.5 million Investors: Eshelman Ventures, Celgene Corp. , TaiAn Technologies Corporation,
Healthlink Capital
...
Read More
BioCentury
|
Jul 18, 2016
Financial News
Sapience completes venture financing
...2016-07-12 Type: Venture financing Raised: $22.5 million Investors: Eshelman Ventures; Celgene Corp. ; TaiAn Technologies;
Healthlink Capital
WIR...
Read More
BioCentury
|
Jul 13, 2016
Financial News
Cancer newco Sapience raises $22.5M
...an untranched series A round led by Eshelman Ventures. Celgene Corp. (NASDAQ:CELG), TaiAn Technologies and
Healthlink Capital
...
Read More
Items per page:
10
1 - 7 of 7
Previous page
Next page